Literature DB >> 6828118

The spirochetal etiology of Lyme disease.

A C Steere, R L Grodzicki, A N Kornblatt, J E Craft, A G Barbour, W Burgdorfer, G P Schmid, E Johnson, S E Malawista.   

Abstract

We recovered a newly recognized spirochete from the blood, skin lesions (erythema chronicum migrans [ECM]), or cerebrospinal fluid of 3 of 56 patients with Lyme disease and from 21 of 110 nymphal or adult lxodes dammini ticks in Connecticut. These isolates and the original one from l. dammini appeared to have the same morphologic and immunologic features. In patients, specific IgM antibody titers usually reached a peak between the third and sixth week after the onset of disease; specific IgG antibody titers rose slowly and were generally highest months later when arthritis was present. Among 40 patients who had early disease only (ECM alone), 90 per cent had an elevated IgM titer (greater than or equal to 1:128) between the ECM phase and convalescence. Among 95 patients with later manifestations (involvement of the nervous system, heart, or joints), 94 per cent had elevated titers of IgG (greater than or equal to 1:128). In contrast, none of 80 control subjects had elevated IgG titers, and only three control patients with infectious mononucleosis had elevated IgM titers. We conclude that the I. dammini spirochete is the causative agent of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6828118     DOI: 10.1056/NEJM198303313081301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  505 in total

Review 1.  How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?

Authors:  D Taylor-Robinson; A Keat
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

2.  Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes.

Authors:  S Y Sung; J V McDowell; R T Marconi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

3.  Telomere resolution in the Lyme disease spirochete.

Authors:  G Chaconas; P E Stewart; K Tilly; J L Bono; P Rosa
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

4.  Quality control assessment of Canadian laboratories testing for Lyme disease.

Authors:  H Artsob; M Garvie
Journal:  Can J Infect Dis       Date:  1991

5.  Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome.

Authors:  J H Wokke; P A van Doorn; A Brand; G M Schreuder; M Vermeulen
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

6.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

7.  Concurrent Borrelia burgdorferi and Babesia microti infection in nymphal Ixodes dammini.

Authors:  J Piesman; T N Mather; S R Telford; A Spielman
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis.

Authors:  M Karlsson; I Möllegård; G Stiernstedt; B Wretlind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

9.  Functional Equivalence of OspA and OspB, but Not OspC, in Tick Colonization by Borrelia burgdorferi.

Authors:  Kit Tilly; Aaron Bestor; Patricia A Rosa
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

10.  Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.

Authors:  B P Fung; G L McHugh; J M Leong; A C Steere
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.